AlphaFold predicted structure
ALDH7A1 · P49419

Mean pLDDT
95.1/ 100
Very high
539 residues
Confidence breakdown
- Very high(≥ 90)94%
- Confident(70–90)1%
- Low(50–70)0%
- Very low(< 50)5%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
aldehyde dehydrogenase 7 family member A1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Neurotransmitter disorders
BIALLELIC, autosomal or pseudoautosomalpyridoxine-dependent epilepsy
pyridoxine-dependent epilepsy caused by ALDH7A1 mutant
hereditary disease
Seizure
epilepsy
Ventriculomegaly
adult-onset autosomal dominant demyelinating leukodystrophy
Neonatal seizure
developmental and epileptic encephalopathy, 13
osteoporosis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Alpha-aminoadipic semialdehyde dehydrogenase
Aldehyde dehydrogenase enzyme that mediates important protective effects (PubMed:16491085, PubMed:20207735, PubMed:20554659, PubMed:21338592, PubMed:25554827, PubMed:31302938, PubMed:31652343, PubMed:38604394, PubMed:40233740). Protects cells from oxidative stress by metabolizing a number of lipid peroxidation-derived aldehydes (PubMed:16491085, PubMed:20207735, PubMed:21338592, PubMed:40233740). Involved in cellular defense against hyperosmotic stress by metabolizing betaine aldehyde to betaine, an important cellular osmolyte and methyl donor (PubMed:20207735)
ALDH7A1 · P49419

Mean pLDDT
95.1/ 100
Very high
539 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0